Atabak Mokari
CIK 1678419 · Chief Financial Officer · last filed 2026-07-17
Atabak Mokari is a Chief Financial Officer who has filed 31 SEC Form 4 insider transactions across 3 companies since 2016. The most recent filing, for CORT, was dated Jul 30, 2026. Across all open-market trades the lifetime net is −$9.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.91M
3
31
-$9.55M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CORT | Chief Financial Officer | 16,130 | $114.49 | $1.85M | -$9.55M | 22 | 2026-07-17 |
| BELLICUM PHARMACEUTICALS, INC (BLCM) Delisted | Chief Financial Officer | — | $0.07 | — | $0 | 3 | 2020-04-09 |
| IRIX | CFO and VP Corp Development | 81,967 | $0.82 | $67.2K | $0 | 4 | 2018-12-13 |
Recent Filings
31 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-30 | CORT | Notice (144) | −40,000 | -$4.59M | EDGAR |
| 2026-07-17 | CORT | Mixed | — | -$2.65M | EDGAR |
| 2026-06-17 | CORT | Mixed | — | -$2.48M | EDGAR |
| 2026-06-03 | CORT | Mixed | +873 | -$2.01M | EDGAR |
| 2026-06-01 | CORT | Notice (144) | −160,000 | -$11.20M | EDGAR |
| 2026-03-04 | CORT | Mixed | +698 | $10.8K | EDGAR |
| 2026-03-03 | CORT | Grant (A) | — | $0 | EDGAR |
| 2025-12-03 | CORT | Mixed | +238 | $4.8K | EDGAR |
| 2025-09-04 | CORT | Mixed | +256 | $4.0K | EDGAR |
| 2025-06-04 | CORT | Mixed | +1,031 | $18.4K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.